New motor outcome function measures in evaluation of Late-Onset Pompe disease before and after enzyme replacement therapy

2012 ◽  
Vol 45 (6) ◽  
pp. 831-834 ◽  
Author(s):  
Corrado Angelini ◽  
Claudio Semplicini ◽  
Sabrina Ravaglia ◽  
Maurizio Moggio ◽  
Giacomo P. Comi ◽  
...  
Keyword(s):  
Enzyme Replacement Therapy ◽  
Replacement Therapy ◽  
Pompe Disease ◽  
Late Onset ◽  
Enzyme Replacement ◽  
Motor Outcome ◽  
Before And After ◽  
Outcome Function

scholarly journals Late-onset Pompe disease: preliminary results of enzyme replacement therapy

2019 ◽  
Vol 9 (2) ◽  
pp. 43-49
Author(s):  
L. P. Smertina ◽  
F. I. Ausheva ◽  
A. V. Gryaznov ◽  
D. A. Svetlakov ◽  
L. N. Kolbasin
Keyword(s):  
Enzyme Replacement Therapy ◽  
Replacement Therapy ◽  
Pompe Disease ◽  
Late Onset ◽  
Respiratory Muscles ◽  
Preliminary Results ◽  
Enzyme Replacement ◽  
Acid Maltase ◽  
Body Tissues ◽  
Before And After

Pompe disease is an orphan hereditary accumulation disease associated with a deficiency of the lysosomal enzyme alglucosidase alpha. Manifestations of the disease are associated with pathological deposition of glycogen in body tissues as a result of GAA gene mutation and subsequent reduction in the activity of the enzyme alglucosidase alpha or acid maltase. The variety of phenotypic forms and varying degrees of damage to the skeletal and respiratory muscles, cardiomyocytes and internal organs greatly complicates the diagnosis and treatment of patients with Pompe»s disease. This article describes the clinical case of late-onset Pompe disease, which was followed by a course of enzyme replacement therapy, as well as an assessment of the condition before and after treatment and preliminary results.

scholarly journals Muscle Proteomic Profile before and after Enzyme Replacement Therapy in Late-Onset Pompe Disease

2021 ◽  
Vol 22 (6) ◽  
pp. 2850
Author(s):  
Manuela Moriggi ◽  
Daniele Capitanio ◽  
Enrica Torretta ◽  
Pietro Barbacini ◽  
Cinzia Bragato ◽  
...  
Keyword(s):  
Enzyme Replacement Therapy ◽  
Replacement Therapy ◽  
Pompe Disease ◽  
Late Onset ◽  
Label Free ◽  
Enzyme Replacement ◽  
Lysosome Biogenesis ◽  
Before And After ◽  
Membrane Reorganization ◽  
Patient’S Outcome

Mutations in the acidic alpha-glucosidase (GAA) coding gene cause Pompe disease. Late-onset Pompe disease (LOPD) is characterized by progressive proximal and axial muscle weakness and atrophy, causing respiratory failure. Enzyme replacement therapy (ERT), based on recombinant human GAA infusions, is the only available treatment; however, the efficacy of ERT is variable. Here we address the question whether proteins at variance in LOPD muscle of patients before and after 1 year of ERT, compared withhealthy age-matched subjects (CTR), reveal a specific signature. Proteins extracted from skeletal muscle of LOPD patients and CTR were analyzed by combining gel based (two-dimensional difference gel electrophoresis) and label-free (liquid chromatography-mass spectrometry) proteomic approaches, and ingenuity pathway analysis. Upstream regulators targeting autophagy and lysosomal tethering were assessed by immunoblotting. 178 proteins were changed in abundance in LOPD patients, 47 of them recovered normal level after ERT. Defects in oxidative metabolism, muscle contractile protein regulation, cytoskeletal rearrangement, and membrane reorganization persisted. Metabolic changes, ER stress and UPR (unfolded protein response) contribute to muscle proteostasis dysregulation with active membrane remodeling (high levels of LC3BII/LC3BI) and accumulation of p62, suggesting imbalance in the autophagic process. Active lysosome biogenesis characterizes both LOPD PRE and POST, unparalleled by molecules involved in lysosome tethering (VAMP8, SNAP29, STX17, and GORASP2) and BNIP3. In conclusion this study reveals a specific signature that suggests ERT prolongation and molecular targets to ameliorate patient’s outcome.

scholarly journals Effects of Exercise Training on Functional Capacity and Quality of Life in a Patient with Late-Onset Pompe Disease Receiving Enzyme Replacement Therapy

2015 ◽  
Vol 2 (s1) ◽  
pp. S33-S33
Author(s):  
Rosângela M. Silva ◽  
Carmen S.C. Mendes ◽  
Carolina C. Aranda ◽  
Marco A. Curiati ◽  
Maret H. Rand ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Exercise Training ◽  
Enzyme Replacement Therapy ◽  
Replacement Therapy ◽  
Functional Capacity ◽  
Pompe Disease ◽  
Late Onset ◽  
Enzyme Replacement

Late-onset Pompe disease after 4 years of enzyme replacement therapy: An autopsy case

2014 ◽  
Vol 2 (1) ◽  
pp. 7-9 ◽  
Author(s):  
Yoshihiko Furusawa ◽  
Satomi Mitsuhashi ◽  
Madoka Mori-Yoshimura ◽  
Yohta Shimada ◽  
Toshiyuki Yamamoto ◽  
...  
Keyword(s):  
Enzyme Replacement Therapy ◽  
Replacement Therapy ◽  
Pompe Disease ◽  
Late Onset ◽  
Autopsy Case ◽  
Enzyme Replacement
Sign in / Sign up

Export Citation Format

Share Document